Colonial Trust Co SC Makes New Investment in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Colonial Trust Co SC bought a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,363 shares of the medical instruments supplier’s stock, valued at approximately $26,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Vanguard Group Inc. grew its holdings in DENTSPLY SIRONA by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock worth $383,078,000 after acquiring an additional 65,478 shares in the last quarter. First Eagle Investment Management LLC lifted its position in shares of DENTSPLY SIRONA by 2.5% during the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock worth $275,218,000 after purchasing an additional 348,532 shares during the last quarter. Nuance Investments LLC grew its stake in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after purchasing an additional 2,708,097 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock valued at $238,186,000 after buying an additional 1,975,404 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. raised its stake in DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock valued at $219,018,000 after buying an additional 314,343 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 15,142 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.52% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on XRAY shares. UBS Group lowered their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a report on Friday. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price target on the stock. in a research report on Tuesday, April 15th. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday. Finally, Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Eleven research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $20.27.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $15.81 on Friday. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $28.69. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market capitalization of $3.15 billion, a price-to-earnings ratio of -7.64, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The business has a 50 day simple moving average of $14.36 and a 200 day simple moving average of $17.58.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $879.00 million during the quarter, compared to analysts’ expectations of $854.75 million. During the same quarter in the prior year, the business posted $0.42 earnings per share. The company’s revenue for the quarter was down 7.8% compared to the same quarter last year. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.05%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.07%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.